NCT04218357View on ClinicalTrials.gov

Probenecid as Medication for Alcohol Use Disorder (PROB)

PHASE1CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

May 16, 2023

Study Completion Date

May 20, 2023

Conditions

Alcohol Use Disorder

Interventions

DRUG

Probenecid or placebo single administration

study drug administration with alcohol in the laboratory

Trial Locations (1)

20923

Brown University, Providence

Sponsors

Lead Sponsor

Brown University

All Listed Sponsors

lead

Brown University

OTHER

NCT04218357 - Probenecid as Medication for Alcohol Use Disorder (PROB) | Biotech Hunter | Biotech Hunter